Gadolinium DTPA
(LGMLJQFQKXPRGA-VPVMAENOSA-K)
Structure
- SMILES
- [O-]C(=O)CN(CCN(CC(=O)O)CC(=O)[O-])CCN(CC(=O)O)CC(=O)[O-].CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.[Gd+3]
- Molecular Formula:
- C28H54GdN5O20
- Molecular Weight:
- 938.000
- Log P:
- -12.6235
- Hydrogen Bond Acceptor:
- 25
- Hydrogen Bond Donor:
- 14
- TPSA:
- 431.07
- CAS Number(s):
- N/A
Synonym(s)
1.
Gadolinium DTPA
2.
Gadopentetate Dimeglumine
3.
Gd-DTPA
4.
Gadolinium DTPA Dimeglumine
5.
Gadolinium DTPA Dimeglumine Salt
6.
Gadolinium DTPA Disodium Salt
7.
Gadolinium Diethylenetriaminepenta-acetic Acid
8.
Gadopentetic Acid
9.
Magnevist
10.
Magnevist Enteral
11.
Magnograf
12.
Magnograf Enteral
13.
DTPA, Gadolinium
14.
Diethylenetriaminepenta-acetic Acid, Gadolinium
15.
Dimeglumine, Gadolinium DTPA
16.
Dimeglumine, Gadopentetate
17.
Gadolinium Diethylenetriaminepenta acetic Acid
18.
Gd DTPA
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Urticaria | FAERS: 907 Canada Vigilance: 29 | Canada Vigilance US FAERS | |
| 2 | Nausea | FAERS: 740 Canada Vigilance: 12 | Canada Vigilance US FAERS | |
| 3 | Vomiting | FAERS: 699 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 4 | Pruritus | FAERS: 478 Canada Vigilance: 16 | Canada Vigilance US FAERS | |
| 5 | Nephrogenic Systemic Fibrosis | FAERS: 347 | US FAERS | |
| 6 | Erythema | FAERS: 283 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 7 | Sneezing | FAERS: 258 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 8 | Dizziness | FAERS: 173 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 9 | Pain | FAERS: 169 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 10 | Chest discomfort | FAERS: 161 Canada Vigilance: 12 | Canada Vigilance US FAERS | |
| 11 | Throat irritation | FAERS: 151 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 12 | Contrast media reaction | FAERS: 135 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 13 | Flushing | FAERS: 125 Canada Vigilance: 8 | Canada Vigilance US FAERS | |
| 14 | Headache | FAERS: 112 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 15 | Nephrogenic Fibrosing Dermopathy | FAERS: 112 | CTD US FAERS | |
| 16 | Anxiety | FAERS: 105 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 17 | Chest Pain | FAERS: 98 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 18 | Burning sensation | FAERS: 90 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 19 | Hypersensitivity | FAERS: 87 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 20 | Arthralgia | FAERS: 81 | US FAERS | |
| 21 | Injection site pain | FAERS: 81 | US FAERS | |
| 22 | Malaise | FAERS: 72 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 23 | Asthenia | FAERS: 66 | US FAERS | |
| 24 | General physical health deterioration | FAERS: 64 | US FAERS | |
| 25 | Emotional distress | FAERS: 63 | US FAERS | |
| 26 | Fibrosis | FAERS: 63 | US FAERS | |
| 27 | Tremor | FAERS: 63 Canada Vigilance: 1 | 9763378 | CTD Canada Vigilance US FAERS |
| 28 | Wheezing | FAERS: 61 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 29 | Injection site erythema | FAERS: 57 | US FAERS | |
| 30 | Dysgeusia | FAERS: 56 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 31 | Adverse event | FAERS: 55 | US FAERS | |
| 32 | No adverse event | FAERS: 55 | US FAERS | |
| 33 | Feeling abnormal | FAERS: 52 | US FAERS | |
| 34 | Lip swelling | FAERS: 48 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 35 | Cardiac Arrest | FAERS: 46 | US FAERS | |
| 36 | Anaphylactic shock | FAERS: 45 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 37 | Musculoskeletal stiffness | FAERS: 44 | US FAERS | |
| 38 | Abdominal Pain | FAERS: 41 | US FAERS | |
| 39 | Respiratory arrest | FAERS: 41 | US FAERS | |
| 40 | Cyanosis | FAERS: 40 | US FAERS | |
| 41 | Hypotension | FAERS: 40 | US FAERS | |
| 42 | Myalgia | FAERS: 36 | US FAERS | |
| 43 | Syncope | FAERS: 36 | US FAERS | |
| 44 | Dysphonia | FAERS: 35 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 45 | Fatigue | FAERS: 35 | US FAERS | |
| 46 | Respiratory distress | FAERS: 35 | US FAERS | |
| 47 | Retching | FAERS: 34 | US FAERS | |
| 48 | Choking sensation | FAERS: 33 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 49 | Depressed Level of Consciousness | FAERS: 33 | US FAERS | |
| 50 | Phlebitis | FAERS: 33 | US FAERS | |
| 51 | Skin tightness | FAERS: 31 | US FAERS | |
| 52 | Tachycardia | FAERS: 31 | US FAERS | |
| 53 | Swelling | FAERS: 30 | US FAERS | |
| 54 | Palpitations | FAERS: 29 | US FAERS | |
| 55 | Rash erythematous | FAERS: 29 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 56 | Anhedonia | FAERS: 28 | US FAERS | |
| 57 | Joint Range of Motion Decreased | FAERS: 28 | US FAERS | |
| 58 | Oropharyngeal discomfort | FAERS: 27 | US FAERS | |
| 59 | Skin Induration | FAERS: 27 | US FAERS | |
| 60 | Cold sweat | FAERS: 26 | US FAERS | |
| 61 | Eye irritation | FAERS: 26 | US FAERS | |
| 62 | Lethargy | FAERS: 26 | US FAERS | |
| 63 | Unevaluable event | FAERS: 26 | US FAERS | |
| 64 | Extravasation | FAERS: 25 | US FAERS | |
| 65 | Injection site extravasation | FAERS: 25 | US FAERS | |
| 66 | Chills | FAERS: 24 | US FAERS | |
| 67 | Muscle tightness | FAERS: 24 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 68 | Pallor | FAERS: 24 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 69 | Skin hypertrophy | FAERS: 24 | US FAERS | |
| 70 | Deformity | FAERS: 23 | US FAERS | |
| 71 | Feeling Cold | FAERS: 23 | US FAERS | |
| 72 | Joint stiffness | FAERS: 23 | US FAERS | |
| 73 | Somnolence | FAERS: 22 | US FAERS | |
| 74 | Unresponsive to stimuli | FAERS: 22 | US FAERS | |
| 75 | Bone pain | FAERS: 20 | US FAERS | |
| 76 | Contrast media allergy | FAERS: 20 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 77 | Nasal discomfort | FAERS: 20 | US FAERS | |
| 78 | Gadolinium deposition disease | FAERS: 19 | US FAERS | |
| 79 | Joint swelling | FAERS: 19 | US FAERS | |
| 80 | Oral pruritus | FAERS: 19 | US FAERS | |
| 81 | Drug ineffective | FAERS: 18 | US FAERS | |
| 82 | Inflammation | FAERS: 18 | US FAERS | |
| 83 | Atrial Fibrillation | FAERS: 17 | US FAERS | |
| 84 | Thrombophlebitis | FAERS: 17 | US FAERS | |
| 85 | Arthropathy | FAERS: 16 | US FAERS | |
| 86 | Visual Impairment | FAERS: 16 | US FAERS | |
| 87 | Injection Site Reaction | FAERS: 15 | US FAERS | |
| 88 | Limb discomfort | FAERS: 15 | US FAERS | |
| 89 | Quality of life decreased | FAERS: 15 | US FAERS | |
| 90 | Back Pain | FAERS: 14 | US FAERS | |
| 91 | Contrast media deposition | FAERS: 14 | US FAERS | |
| 92 | Post procedural complication | FAERS: 14 | US FAERS | |
| 93 | Procedural complication | FAERS: 14 | US FAERS | |
| 94 | Renal pain | FAERS: 14 | US FAERS | |
| 95 | Thrombosis | FAERS: 14 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 96 | Tinnitus | FAERS: 14 | US FAERS | |
| 97 | Injection site irritation | FAERS: 13 | US FAERS | |
| 98 | Nervousness | FAERS: 13 | US FAERS | |
| 99 | Agitation | FAERS: 12 | US FAERS | |
| 100 | Dermatitis | FAERS: 12 | US FAERS | |
| 101 | Discomfort | FAERS: 12 | US FAERS | |
| 102 | Productive Cough | FAERS: 12 | US FAERS | |
| 103 | Abdominal discomfort | FAERS: 11 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 104 | Hypoaesthesia facial | FAERS: 11 | US FAERS | |
| 105 | Incontinence | FAERS: 11 | US FAERS | |
| 106 | Injection site thrombosis | FAERS: 11 | US FAERS | |
| 107 | Shock | FAERS: 11 | US FAERS | |
| 108 | Anaphylactoid Reaction | FAERS: 10 | US FAERS | |
| 109 | Bradycardia | FAERS: 10 | 9110026 | CTD US FAERS |
| 110 | Bronchospasm | FAERS: 10 | US FAERS | |
| 111 | Cellulitis | FAERS: 10 | US FAERS | |
| 112 | Dysarthria | FAERS: 10 | US FAERS | |
| 113 | Hypoxia | FAERS: 10 | US FAERS | |
| 114 | Incorrect route of drug administration | FAERS: 10 | US FAERS | |
| 115 | Injection site phlebitis | FAERS: 10 | US FAERS | |
| 116 | Mental status changes | FAERS: 10 | US FAERS | |
| 117 | Oropharyngeal swelling | FAERS: 10 | US FAERS | |
| 118 | Vertigo | FAERS: 10 | US FAERS | |
| 119 | Amnesia | FAERS: 9 | US FAERS | |
| 120 | Aphasia | FAERS: 9 | US FAERS | |
| 121 | Dry skin | FAERS: 9 | US FAERS | |
| 122 | Lymphadenopathy | FAERS: 9 | US FAERS | |
| 123 | Presyncope | FAERS: 9 | US FAERS | |
| 124 | Scleroderma | FAERS: 9 | US FAERS | |
| 125 | Sepsis | FAERS: 9 | US FAERS | |
| 126 | Skin lesion | FAERS: 9 | US FAERS | |
| 127 | Tongue pruritus | FAERS: 9 | US FAERS | |
| 128 | Weight decreased | FAERS: 9 | US FAERS | |
| 129 | Alopecia | FAERS: 8 | US FAERS | |
| 130 | Dysuria | FAERS: 8 | US FAERS | |
| 131 | Musculoskeletal Pain | FAERS: 8 | US FAERS | |
| 132 | Oropharyngeal pain | FAERS: 8 | US FAERS | |
| 133 | Polyneuropathy | FAERS: 8 | US FAERS | |
| 134 | Respiratory tract congestion | FAERS: 8 | US FAERS | |
| 135 | Restlessness | FAERS: 8 | US FAERS | |
| 136 | Urticaria localised | FAERS: 8 | US FAERS | |
| 137 | Anuria | FAERS: 7 | 15221265 | CTD US FAERS |
| 138 | Deafness | FAERS: 7 | US FAERS | |
| 139 | Disorientation | FAERS: 7 | US FAERS | |
| 140 | Drug administration error | FAERS: 7 | US FAERS | |
| 141 | Dyspepsia | FAERS: 7 | US FAERS | |
| 142 | Foaming at mouth | FAERS: 7 | US FAERS | |
| 143 | Hemiparesis | FAERS: 7 | US FAERS | |
| 144 | Injection site inflammation | FAERS: 7 | US FAERS | |
| 145 | Injection site mass | FAERS: 7 | US FAERS | |
| 146 | Lip pruritus | FAERS: 7 | US FAERS | |
| 147 | Musculoskeletal discomfort | FAERS: 7 | US FAERS | |
| 148 | Mydriasis | FAERS: 7 | US FAERS | |
| 149 | Pulmonary Fibrosis | FAERS: 7 | US FAERS | |
| 150 | Renal tubular disorder | FAERS: 7 | US FAERS | |
| 151 | Sudden death | FAERS: 7 | US FAERS | |
| 152 | Trismus | FAERS: 7 | US FAERS | |
| 153 | Anger | FAERS: 6 | US FAERS | |
| 154 | Aphagia | FAERS: 6 | US FAERS | |
| 155 | Blood pressure immeasurable | FAERS: 6 | US FAERS | |
| 156 | Crying | FAERS: 6 | US FAERS | |
| 157 | Drug exposure during pregnancy | FAERS: 6 | US FAERS | |
| 158 | Drug level changed | FAERS: 6 | US FAERS | |
| 159 | Extremity contracture | FAERS: 6 | US FAERS | |
| 160 | Facial Pain | FAERS: 6 | US FAERS | |
| 161 | Formication | FAERS: 6 | US FAERS | |
| 162 | Head discomfort | FAERS: 6 | US FAERS | |
| 163 | Myocardial Infarction | FAERS: 6 | US FAERS | |
| 164 | Neurological examination abnormal | FAERS: 6 | US FAERS | |
| 165 | Pulmonary Embolism | FAERS: 6 | US FAERS | |
| 166 | Stress | FAERS: 6 | US FAERS | |
| 167 | Urinary Incontinence | FAERS: 6 | US FAERS | |
| 168 | Asphyxia | FAERS: 5 | US FAERS | |
| 169 | Cardiovascular insufficiency | FAERS: 5 | US FAERS | |
| 170 | Cerebrovascular accident | FAERS: 5 | US FAERS | |
| 171 | Claustrophobia | FAERS: 5 | US FAERS | |
| 172 | Conjunctivitis | FAERS: 5 | US FAERS | |
| 173 | Constipation | FAERS: 5 | US FAERS | |
| 174 | Diplopia | FAERS: 5 | US FAERS | |
| 175 | Drug toxicity | FAERS: 5 | US FAERS | |
| 176 | Hyperkeratosis | FAERS: 5 | US FAERS | |
| 177 | Hyperventilation | FAERS: 5 | US FAERS | |
| 178 | Incorrect dose administered | FAERS: 5 | US FAERS | |
| 179 | Infection | FAERS: 5 | US FAERS | |
| 180 | Injection site discomfort | FAERS: 5 | US FAERS | |
| 181 | Injection site pruritus | FAERS: 5 | US FAERS | |
| 182 | Lividity | FAERS: 5 | US FAERS | |
| 183 | Medication Error | FAERS: 5 | US FAERS | |
| 184 | Mental impairment | FAERS: 5 | US FAERS | |
| 185 | Nontherapeutic agent urine positive | FAERS: 5 | US FAERS | |
| 186 | Nystagmus | FAERS: 5 | US FAERS | |
| 187 | Peripheral swelling | FAERS: 5 | US FAERS | |
| 188 | Pharyngolaryngeal discomfort | FAERS: 5 | US FAERS | |
| 189 | Product quality issue | FAERS: 5 | US FAERS | |
| 190 | Rhinitis | FAERS: 5 | US FAERS | |
| 191 | Stridor | FAERS: 5 | US FAERS | |
| 192 | Tension Headache | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 193 | Thirst | FAERS: 5 | US FAERS | |
| 194 | Toothache | FAERS: 5 | US FAERS | |
| 195 | Vein pain | FAERS: 5 | US FAERS | |
| 196 | Altered state of consciousness | FAERS: 4 | US FAERS | |
| 197 | Asthma | FAERS: 4 | US FAERS | |
| 198 | Auricular swelling | FAERS: 4 | US FAERS | |
| 199 | Cerebral Infarction | FAERS: 4 | US FAERS | |
| 200 | Deep Vein Thrombosis | FAERS: 4 | US FAERS | |
| 201 | Drug screen positive | FAERS: 4 | US FAERS | |
| 202 | Ear discomfort | FAERS: 4 | US FAERS | |
| 203 | Exfoliative rash | FAERS: 4 | US FAERS | |
| 204 | Eye pain | FAERS: 4 | US FAERS | |
| 205 | Flank Pain | FAERS: 4 | US FAERS | |
| 206 | Granuloma | FAERS: 4 | US FAERS | |
| 207 | Hypertrophy | FAERS: 4 | US FAERS | |
| 208 | Impaired work ability | FAERS: 4 | US FAERS | |
| 209 | Increased upper airway secretion | FAERS: 4 | US FAERS | |
| 210 | Injection site nodule | FAERS: 4 | US FAERS | |
| 211 | Laryngospasm | FAERS: 4 | US FAERS | |
| 212 | Lymphangitis | FAERS: 4 | US FAERS | |
| 213 | Lymphopenia | FAERS: 4 | US FAERS | |
| 214 | Medication residue present | FAERS: 4 | US FAERS | |
| 215 | Memory impairment | FAERS: 4 | US FAERS | |
| 216 | Muscle Fatigue | FAERS: 4 | US FAERS | |
| 217 | Nodule | FAERS: 4 | US FAERS | |
| 218 | Nonspecific reaction | FAERS: 4 | US FAERS | |
| 219 | Pain of skin | FAERS: 4 | US FAERS | |
| 220 | Paraparesis | FAERS: 4 | US FAERS | |
| 221 | Post-Traumatic Stress Disorder | FAERS: 4 | US FAERS | |
| 222 | Retrograde amnesia | FAERS: 4 | US FAERS | |
| 223 | Septic arthritis staphylococcal | FAERS: 4 | US FAERS | |
| 224 | Skin Ulcer | FAERS: 4 | US FAERS | |
| 225 | Skin Wrinkling | FAERS: 4 | US FAERS | |
| 226 | Toxicity to various agents | FAERS: 4 | US FAERS | |
| 227 | Visual disturbance | FAERS: 4 | US FAERS | |
| 228 | nervous system disorder | FAERS: 4 | US FAERS | |
| 229 | Accidental exposure to product | FAERS: 3 | US FAERS | |
| 230 | Angioedema | FAERS: 3 | US FAERS | |
| 231 | Arachnoiditis | FAERS: 3 | US FAERS | |
| 232 | Arteriosclerosis | FAERS: 3 | US FAERS | |
| 233 | Aspartate Aminotransferase Increased | FAERS: 3 | US FAERS | |
| 234 | Blood creatine increased | FAERS: 3 | US FAERS | |
| 235 | Blood creatinine increased | FAERS: 3 | US FAERS | |
| 236 | Blood urea increased | FAERS: 3 | US FAERS | |
| 237 | Cachexia | FAERS: 3 | US FAERS | |
| 238 | Carpal Tunnel Syndrome | FAERS: 3 | US FAERS | |
| 239 | Choking | FAERS: 3 | US FAERS | |
| 240 | Debridement | FAERS: 3 | US FAERS | |
| 241 | Disease Progression | FAERS: 3 | US FAERS | |
| 242 | Eczema | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 243 | Feeling of body temperature change | FAERS: 3 | US FAERS | |
| 244 | Gout | FAERS: 3 | US FAERS | |
| 245 | Hypertensive crisis | FAERS: 3 | US FAERS | |
| 246 | Infusion Site Extravasation | FAERS: 3 | US FAERS | |
| 247 | Injection site bruising | FAERS: 3 | US FAERS | |
| 248 | Injection site coldness | FAERS: 3 | US FAERS | |
| 249 | Injection site movement impairment | FAERS: 3 | US FAERS | |
| 250 | Injection site streaking | FAERS: 3 | US FAERS | |
| 251 | Injection site urticaria | FAERS: 3 | US FAERS | |
| 252 | Intentional self-injury | FAERS: 3 | US FAERS | |
| 253 | Laceration | FAERS: 3 | US FAERS | |
| 254 | Lymphadenitis | FAERS: 3 | US FAERS | |
| 255 | Maternal exposure during pregnancy | FAERS: 3 | US FAERS | |
| 256 | Muscle Rigidity | FAERS: 3 | US FAERS | |
| 257 | Musculoskeletal chest pain | FAERS: 3 | US FAERS | |
| 258 | Neck Pain | FAERS: 3 | US FAERS | |
| 259 | Neuralgia | FAERS: 3 | US FAERS | |
| 260 | Pharyngitis | FAERS: 3 | US FAERS | |
| 261 | Product use issue | FAERS: 3 | US FAERS | |
| 262 | Respiratory Failure | FAERS: 3 | US FAERS | |
| 263 | Restless Legs Syndrome | FAERS: 3 | US FAERS | |
| 264 | Sense of oppression | FAERS: 3 | US FAERS | |
| 265 | Sinus headache | FAERS: 3 | US FAERS | |
| 266 | Skin discomfort | FAERS: 3 | US FAERS | |
| 267 | Skin irritation | FAERS: 3 | US FAERS | |
| 268 | Skin test positive | FAERS: 3 | US FAERS | |
| 269 | Syringe issue | FAERS: 3 | US FAERS | |
| 270 | Urinary tract infection | FAERS: 3 | US FAERS | |
| 271 | Vasospasm | FAERS: 3 | US FAERS | |
| 272 | Venous Thrombosis | FAERS: 3 | US FAERS | |
| 273 | Venous thrombosis limb | FAERS: 3 | US FAERS | |
| 274 | Vessel puncture site pain | FAERS: 3 | US FAERS | |
| 275 | Vestibular Neuronitis | FAERS: 3 | US FAERS | |
| 276 | Wrong technique in drug usage process | FAERS: 3 | US FAERS | |
| 277 | Yawning | FAERS: 3 | US FAERS | |
| 278 | Abasia | FAERS: 2 | US FAERS | |
| 279 | Abdominal adhesions | FAERS: 2 | US FAERS | |
| 280 | Acne | FAERS: 2 | US FAERS | |
| 281 | Adams-Stokes Syndrome | FAERS: 2 | US FAERS | |
| 282 | Alanine Aminotransferase Increased | FAERS: 2 | US FAERS | |
| 283 | Aphonia | FAERS: 2 | US FAERS | |
| 284 | Arthritis | FAERS: 2 | US FAERS | |
| 285 | Blindness | FAERS: 2 | US FAERS | |
| 286 | Blood glucose increased | FAERS: 2 | US FAERS | |
| 287 | Blood potassium decreased | FAERS: 2 | US FAERS | |
| 288 | Bronchial Obstruction | FAERS: 2 | US FAERS | |
| 289 | Cardiac enzymes increased | FAERS: 2 | US FAERS | |
| 290 | Central nervous system lesion | FAERS: 2 | US FAERS | |
| 291 | Cerebral atrophy | FAERS: 2 | US FAERS | |
| 292 | Dark circles under eyes | FAERS: 2 | US FAERS | |
| 293 | Delirium | FAERS: 2 | US FAERS | |
| 294 | Demyelination | FAERS: 2 | US FAERS | |
| 295 | Depressed mood | FAERS: 2 | US FAERS | |
| 296 | Disability | FAERS: 2 | US FAERS | |
| 297 | Drooling | FAERS: 2 | US FAERS | |
| 298 | Drug clearance decreased | FAERS: 2 | US FAERS | |
| 299 | Electrocardiogram ST segment abnormal | FAERS: 2 | US FAERS | |
| 300 | Electrocardiogram abnormal | FAERS: 2 | US FAERS | |
| 301 | Epigastric discomfort | FAERS: 2 | US FAERS | |
| 302 | Epistaxis | FAERS: 2 | US FAERS | |
| 303 | Eructation | FAERS: 2 | US FAERS | |
| 304 | Feeling jittery | FAERS: 2 | US FAERS | |
| 305 | Femoral arterial stenosis | FAERS: 2 | US FAERS | |
| 306 | General physical condition abnormal | FAERS: 2 | US FAERS | |
| 307 | Genital erythema | FAERS: 2 | US FAERS | |
| 308 | Genital tract inflammation | FAERS: 2 | US FAERS | |
| 309 | Grip strength decreased | FAERS: 2 | US FAERS | |
| 310 | Hepatomegaly | FAERS: 2 | US FAERS | |
| 311 | Hyperexplexia | FAERS: 2 | US FAERS | |
| 312 | Hypoventilation | FAERS: 2 | US FAERS | |
| 313 | Ileus | FAERS: 2 | US FAERS | |
| 314 | Incoherent | FAERS: 2 | US FAERS | |
| 315 | Increased tendency to bruise | FAERS: 2 | US FAERS | |
| 316 | Infusion site pain | FAERS: 2 | US FAERS | |
| 317 | Infusion site thrombosis | FAERS: 2 | US FAERS | |
| 318 | Injection site necrosis | FAERS: 2 | US FAERS | |
| 319 | Iodine allergy | FAERS: 2 | US FAERS | |
| 320 | Joint sprain | FAERS: 2 | US FAERS | |
| 321 | Limb injury | FAERS: 2 | US FAERS | |
| 322 | Metabolic acidosis | FAERS: 2 | US FAERS | |
| 323 | Myopathy | FAERS: 2 | US FAERS | |
| 324 | Nephrectomy | FAERS: 2 | US FAERS | |
| 325 | Nephrolithiasis | FAERS: 2 | US FAERS | |
| 326 | Night sweats | FAERS: 2 | US FAERS | |
| 327 | Occupational exposure to product | FAERS: 2 | US FAERS | |
| 328 | Ocular icterus | FAERS: 2 | US FAERS | |
| 329 | Overdose | FAERS: 2 | US FAERS | |
| 330 | Palmar erythema | FAERS: 2 | US FAERS | |
| 331 | Pancreatitis | FAERS: 2 | US FAERS | |
| 332 | Paranasal sinus hypersecretion | FAERS: 2 | US FAERS | |
| 333 | Pharyngolaryngeal Pain | FAERS: 2 | US FAERS | |
| 334 | Physical disability | FAERS: 2 | US FAERS | |
| 335 | Pneumonia | FAERS: 2 | US FAERS | |
| 336 | Pneumothorax | FAERS: 2 | US FAERS | |
| 337 | Pre-Eclampsia | FAERS: 2 | US FAERS | |
| 338 | Product container issue | FAERS: 2 | US FAERS | |
| 339 | Product deposit | FAERS: 2 | US FAERS | |
| 340 | Pulmonary congestion | FAERS: 2 | US FAERS | |
| 341 | Rales | FAERS: 2 | US FAERS | |
| 342 | Renal Artery Stenosis | FAERS: 2 | US FAERS | |
| 343 | Renal cyst | FAERS: 2 | US FAERS | |
| 344 | Secretion discharge | FAERS: 2 | US FAERS | |
| 345 | Shoulder Pain | FAERS: 2 | US FAERS | |
| 346 | Sinus Tachycardia | FAERS: 2 | US FAERS | |
| 347 | Skin nodule | FAERS: 2 | US FAERS | |
| 348 | Temperature intolerance | FAERS: 2 | US FAERS | |
| 349 | Tension | FAERS: 2 | US FAERS | |
| 350 | Transaminases increased | FAERS: 2 | US FAERS | |
| 351 | Unresponsive to verbal stimuli | FAERS: 2 | US FAERS | |
| 352 | Upper airway obstruction | FAERS: 2 | US FAERS | |
| 353 | Upper respiratory tract congestion | FAERS: 2 | US FAERS | |
| 354 | Vasculitis | FAERS: 2 | US FAERS | |
| 355 | Venipuncture site swelling | FAERS: 2 | US FAERS | |
| 356 | Ventricular Fibrillation | FAERS: 2 | US FAERS | |
| 357 | Wrong drug administered | FAERS: 2 | US FAERS | |
| 358 | Abdominal Abscess | FAERS: 1 | US FAERS | |
| 359 | Activities of daily living impaired | FAERS: 1 | US FAERS | |
| 360 | Acute myocardial infarction | FAERS: 1 | US FAERS | |
| 361 | Altered visual depth perception | FAERS: 1 | US FAERS | |
| 362 | Alveolitis | FAERS: 1 | US FAERS | |
| 363 | Amnestic Disorder | FAERS: 1 | US FAERS | |
| 364 | Angina Pectoris | FAERS: 1 | US FAERS | |
| 365 | Angle Closure Glaucoma | FAERS: 1 | US FAERS | |
| 366 | Anorexia | FAERS: 1 | US FAERS | |
| 367 | Anoxic Encephalopathy | FAERS: 1 | US FAERS | |
| 368 | Arterial Injury | FAERS: 1 | US FAERS | |
| 369 | Arterial fibrosis | FAERS: 1 | US FAERS | |
| 370 | Arthrogram | FAERS: 1 | US FAERS | |
| 371 | Arthropod bite | FAERS: 1 | US FAERS | |
| 372 | Autoimmune thyroiditis | FAERS: 1 | US FAERS | |
| 373 | Bladder dysfunction | FAERS: 1 | US FAERS | |
| 374 | Blepharospasm | FAERS: 1 | US FAERS | |
| 375 | Blood brain barrier defect | FAERS: 1 | US FAERS | |
| 376 | Blood cholesterol increased | FAERS: 1 | US FAERS | |
| 377 | Blood glucose decreased | FAERS: 1 | US FAERS | |
| 378 | Blood immunoglobulin E increased | FAERS: 1 | US FAERS | |
| 379 | Blood mercury abnormal | FAERS: 1 | US FAERS | |
| 380 | Blood potassium increased | FAERS: 1 | US FAERS | |
| 381 | Blood pressure fluctuation | FAERS: 1 | US FAERS | |
| 382 | Blood pressure orthostatic abnormal | FAERS: 1 | US FAERS | |
| 383 | Blood sodium decreased | FAERS: 1 | US FAERS | |
| 384 | Blood thyroid stimulating hormone increased | FAERS: 1 | US FAERS | |
| 385 | Blood urine present | FAERS: 1 | US FAERS | |
| 386 | Body temperature fluctuation | FAERS: 1 | US FAERS | |
| 387 | Brain scan abnormal | FAERS: 1 | US FAERS | |
| 388 | Breast Cyst | FAERS: 1 | US FAERS | |
| 389 | Bruxism | FAERS: 1 | US FAERS | |
| 390 | Carbon dioxide decreased | FAERS: 1 | US FAERS | |
| 391 | Cardiac discomfort | FAERS: 1 | US FAERS | |
| 392 | Cardiac stress test abnormal | FAERS: 1 | US FAERS | |
| 393 | Cheilitis | FAERS: 1 | US FAERS | |
| 394 | Cholelithiasis | FAERS: 1 | US FAERS | |
| 395 | Chorea | FAERS: 1 | US FAERS | |
| 396 | Chromaturia | FAERS: 1 | US FAERS | |
| 397 | Consciousness fluctuating | FAERS: 1 | US FAERS | |
| 398 | Contrast encephalopathy | FAERS: 1 | US FAERS | |
| 399 | Coronary Artery Disease | FAERS: 1 | US FAERS | |
| 400 | Creatinine urine decreased | FAERS: 1 | US FAERS | |
| 401 | Dehydration | FAERS: 1 | US FAERS | |
| 402 | Dementia | FAERS: 1 | US FAERS | |
| 403 | Diplegia | FAERS: 1 | US FAERS | |
| 404 | Documented hypersensitivity to administered drug | FAERS: 1 | US FAERS | |
| 405 | Drug dispensing error | FAERS: 1 | US FAERS | |
| 406 | Drug level increased | FAERS: 1 | US FAERS | |
| 407 | Drug prescribing error | FAERS: 1 | US FAERS | |
| 408 | Dyslexia | FAERS: 1 | US FAERS | |
| 409 | Dystonia | FAERS: 1 | US FAERS | |
| 410 | Ear congestion | FAERS: 1 | US FAERS | |
| 411 | Economic problem | FAERS: 1 | US FAERS | |
| 412 | Electroencephalogram abnormal | FAERS: 1 | US FAERS | |
| 413 | Electromechanical dissociation | FAERS: 1 | US FAERS | |
| 414 | Emotional disorder | FAERS: 1 | US FAERS | |
| 415 | Endometrial thickening | FAERS: 1 | US FAERS | |
| 416 | Epilepsy | FAERS: 1 | US FAERS | |
| 417 | Erythropsia | FAERS: 1 | US FAERS | |
| 418 | Executive dysfunction | FAERS: 1 | US FAERS | |
| 419 | Extra dose administered | FAERS: 1 | US FAERS | |
| 420 | Extremity necrosis | FAERS: 1 | US FAERS | |
| 421 | Eye Burns | FAERS: 1 | US FAERS | |
| 422 | Eye inflammation | FAERS: 1 | US FAERS | |
| 423 | Eyelids pruritus | FAERS: 1 | US FAERS | |
| 424 | Femoral artery occlusion | FAERS: 1 | US FAERS | |
| 425 | Flatulence | FAERS: 1 | US FAERS | |
| 426 | Food Allergy | FAERS: 1 | US FAERS | |
| 427 | Gamma-Glutamyltransferase Increased | FAERS: 1 | US FAERS | |
| 428 | Gastritis | FAERS: 1 | US FAERS | |
| 429 | Gastrointestinal motility disorder | FAERS: 1 | US FAERS | |
| 430 | Glossoptosis | FAERS: 1 | US FAERS | |
| 431 | Hoarseness | FAERS: 1 | US FAERS | |
| 432 | Hormone level abnormal | FAERS: 1 | US FAERS | |
| 433 | Hyperacusis | FAERS: 1 | US FAERS | |
| 434 | Hyperpyrexia | FAERS: 1 | US FAERS | |
| 435 | Hyperreflexia | FAERS: 1 | US FAERS | |
| 436 | Hypertensive heart disease | FAERS: 1 | US FAERS | |
| 437 | Hypertrophic Cardiomyopathy | FAERS: 1 | US FAERS | |
| 438 | Hypophagia | FAERS: 1 | US FAERS | |
| 439 | Impaired driving ability | FAERS: 1 | US FAERS | |
| 440 | Impaired self-care | FAERS: 1 | US FAERS | |
| 441 | Induration | FAERS: 1 | US FAERS | |
| 442 | Infusion site erythema | FAERS: 1 | US FAERS | |
| 443 | Infusion site reaction | FAERS: 1 | US FAERS | |
| 444 | Injection site cellulitis | FAERS: 1 | US FAERS | |
| 445 | Injection site warmth | FAERS: 1 | US FAERS | |
| 446 | Intentional product use issue | FAERS: 1 | US FAERS | |
| 447 | Intermittent Claudication | FAERS: 1 | US FAERS | |
| 448 | Intracranial Aneurysm | FAERS: 1 | US FAERS | |
| 449 | Irritable Bowel Syndrome | FAERS: 1 | US FAERS | |
| 450 | Joint injury | FAERS: 1 | US FAERS | |
| 451 | Laryngeal discomfort | FAERS: 1 | US FAERS | |
| 452 | Ligament rupture | FAERS: 1 | US FAERS | |
| 453 | Livedo Reticularis | FAERS: 1 | US FAERS | |
| 454 | Loss of proprioception | FAERS: 1 | US FAERS | |
| 455 | Malignant neoplasm progression | FAERS: 1 | US FAERS | |
| 456 | Medical device complication | FAERS: 1 | US FAERS | |
| 457 | Medical device removal | FAERS: 1 | US FAERS | |
| 458 | Metamorphopsia | FAERS: 1 | US FAERS | |
| 459 | Moaning | FAERS: 1 | US FAERS | |
| 460 | Monoparesis | FAERS: 1 | US FAERS | |
| 461 | Monoplegia | FAERS: 1 | US FAERS | |
| 462 | Myelofibrosis | FAERS: 1 | US FAERS | |
| 463 | Myoclonus | FAERS: 1 | US FAERS | |
| 464 | Nasal pruritus | FAERS: 1 | US FAERS | |
| 465 | Neonatal disorder | FAERS: 1 | US FAERS | |
| 466 | Nephrocalcinosis | FAERS: 1 | US FAERS | |
| 467 | Nerve injury | FAERS: 1 | US FAERS | |
| 468 | No adverse reaction | FAERS: 1 | US FAERS | |
| 469 | Nontherapeutic agent blood positive | FAERS: 1 | US FAERS | |
| 470 | Nuclear magnetic resonance imaging thoracic abnormal | FAERS: 1 | US FAERS | |
| 471 | Ocular discomfort | FAERS: 1 | US FAERS | |
| 472 | Ocular surface disease | FAERS: 1 | US FAERS | |
| 473 | Onychomycosis | FAERS: 1 | US FAERS | |
| 474 | Optic Atrophy | FAERS: 1 | US FAERS | |
| 475 | Oropharyngeal blistering | FAERS: 1 | US FAERS | |
| 476 | Osteoporosis | FAERS: 1 | US FAERS | |
| 477 | Papule | FAERS: 1 | US FAERS | |
| 478 | Paranoia | FAERS: 1 | US FAERS | |
| 479 | Pelvic Pain | FAERS: 1 | US FAERS | |
| 480 | Peripheral occlusive disease | FAERS: 1 | US FAERS | |
| 481 | Peritoneal Dialysis | FAERS: 1 | US FAERS | |
| 482 | Petechiae | FAERS: 1 | US FAERS | |
| 483 | Pharmaceutical product complaint | FAERS: 1 | US FAERS | |
| 484 | Photophobia | FAERS: 1 | US FAERS | |
| 485 | Pneumonitis | FAERS: 1 | US FAERS | |
| 486 | Polydipsia | FAERS: 1 | US FAERS | |
| 487 | Poor peripheral circulation | FAERS: 1 | US FAERS | |
| 488 | Poor quality drug administered | FAERS: 1 | US FAERS | |
| 489 | Post procedural infection | FAERS: 1 | US FAERS | |
| 490 | Post-tussive vomiting | FAERS: 1 | US FAERS | |
| 491 | Pregnancy | FAERS: 1 | US FAERS | |
| 492 | Prescribed overdose | FAERS: 1 | US FAERS | |
| 493 | Procedural dizziness | FAERS: 1 | US FAERS | |
| 494 | Product packaging issue | FAERS: 1 | US FAERS | |
| 495 | Product residue present | FAERS: 1 | US FAERS | |
| 496 | Product sterility lacking | FAERS: 1 | US FAERS | |
| 497 | Progesterone decreased | FAERS: 1 | US FAERS | |
| 498 | Prolactinoma | FAERS: 1 | US FAERS | |
| 499 | Pulmonary granuloma | FAERS: 1 | US FAERS | |
| 500 | Purpura | FAERS: 1 | US FAERS | |
| 501 | Reactive gastropathy | FAERS: 1 | US FAERS | |
| 502 | Rheumatic disorder | FAERS: 1 | US FAERS | |
| 503 | Ruptured cerebral aneurysm | FAERS: 1 | US FAERS | |
| 504 | Saliva altered | FAERS: 1 | US FAERS | |
| 505 | Scab | FAERS: 1 | US FAERS | |
| 506 | Scan abdomen abnormal | FAERS: 1 | US FAERS | |
| 507 | Scotoma | FAERS: 1 | US FAERS | |
| 508 | Screaming | FAERS: 1 | US FAERS | |
| 509 | Seizure like phenomena | FAERS: 1 | US FAERS | |
| 510 | Septic Shock | FAERS: 1 | US FAERS | |
| 511 | Sinus Arrhythmia | FAERS: 1 | US FAERS | |
| 512 | Skin reaction | FAERS: 1 | US FAERS | |
| 513 | Spinal column stenosis | FAERS: 1 | US FAERS | |
| 514 | Spinal fusion surgery | FAERS: 1 | US FAERS | |
| 515 | Sputum retention | FAERS: 1 | US FAERS | |
| 516 | Stupor | FAERS: 1 | US FAERS | |
| 517 | Subcutaneous nodule | FAERS: 1 | US FAERS | |
| 518 | Suppressed lactation | FAERS: 1 | US FAERS | |
| 519 | Suprapubic pain | FAERS: 1 | US FAERS | |
| 520 | Supraventricular tachycardia | FAERS: 1 | US FAERS | |
| 521 | Suspected counterfeit product | FAERS: 1 | US FAERS | |
| 522 | Swelling of eyelid | FAERS: 1 | US FAERS | |
| 523 | Tetany | FAERS: 1 | US FAERS | |
| 524 | Therapy non-responder | FAERS: 1 | US FAERS | |
| 525 | Thermoanaesthesia | FAERS: 1 | US FAERS | |
| 526 | Thrombocytopenia | FAERS: 1 | US FAERS | |
| 527 | Thyroid Neoplasm | FAERS: 1 | US FAERS | |
| 528 | Tongue blistering | FAERS: 1 | US FAERS | |
| 529 | Torticollis | FAERS: 1 | US FAERS | |
| 530 | Troponin increased | FAERS: 1 | US FAERS | |
| 531 | Tuberculosis | FAERS: 1 | US FAERS | |
| 532 | Urine arsenic increased | FAERS: 1 | US FAERS | |
| 533 | Urine flow decreased | FAERS: 1 | US FAERS | |
| 534 | Venous Insufficiency | FAERS: 1 | US FAERS | |
| 535 | Venous stasis | FAERS: 1 | US FAERS | |
| 536 | Vessel puncture site reaction | FAERS: 1 | US FAERS | |
| 537 | Vitreous floaters | FAERS: 1 | US FAERS | |
| 538 | Walking aid user | FAERS: 1 | US FAERS | |
| 539 | Wheelchair user | FAERS: 1 | US FAERS | |
| 540 | Acute kidney injury | 18472687 | CTD | |
| 541 | Albuminuria | 9419624 | CTD | |
| 542 | Anemia | 15530636 | CTD | |
| 543 | Ataxia | 9763378 | CTD | |
| 544 | Kidney Diseases | CTD | ||
| 545 | Pharyngeal swelling | Canada Vigilance: 1 | Canada Vigilance | |
| 546 | Pituitary Apoplexy | 9401663 | CTD | |
| 547 | Renal Insufficiency | 8175311 | CTD | |
| 548 | Tachycardia, Ventricular | 9110026 | CTD | |
| 549 | Ventricular Dysfunction, Left | 9110026 | CTD | |
| 550 | heart rate | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.